Evidence map›Paper›PMID 33315009›Full record

ArticleeLife2020

Structure of dual BON-domain protein DolP identifies phospholipid binding as a new mechanism for protein localisation.

Jack Alfred Bryant, Faye C Morris, Timothy J Knowles, Riyaz Maderbocus, Eva Heinz, Gabriela Boelter, Dema Alodaini, Adam Colyer, Peter J Wotherspoon, Kara A Staunton and 19 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Bacterial lipid biophysics and membrane organization.Current opinion in microbiology · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Multifaceted membrane binding head of the SARS-CoV-2 spike protein.Current research in structural biology · 2022
    Article
  16. Article
  17. BonA frommBio · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 6 institutions in 4 countries.

Jack Alfred Bryant *Institute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.ORCID 0000-0002-7912-2144
Faye C Morris *Institute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.ORCID 0000-0002-9021-0452
Timothy J Knowles *Institute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Riyaz MaderbocusInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Eva HeinzInfection & Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.ORCID 0000-0003-4413-3756
Gabriela BoelterInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Dema AlodainiInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Adam ColyerInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Peter J WotherspoonInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Kara A StauntonInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Mark JeevesInstitute for Cancer and Genomic Sciences, University of Birmingham, Edgbaston, United Kingdom.
Douglas F BrowningInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Yanina R SevastsyanovichInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Timothy J WellsInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Amanda E RossiterInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Vassiliy N BavroInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Pooja SridharSchool of Biosciences, University of Birmingham, Edgbaston, United Kingdom.
Douglas G WardSchool of Biosciences, University of Birmingham, Edgbaston, United Kingdom.
Zhi-Soon ChongDepartment of Chemistry, National University of Singapore, Singapore, Singapore.
Emily Ca GoodallInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.ORCID 0000-0003-4846-6566
Christopher IckeInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.ORCID 0000-0002-7815-8591
Alvin Ck TeoSchool of Life Sciences, The University of Warwick, Coventry, United Kingdom.
Shu-Sin ChngDepartment of Chemistry, National University of Singapore, Singapore, Singapore.ORCID 0000-0001-5466-7183
David I RoperSchool of Life Sciences, The University of Warwick, Coventry, United Kingdom.
Trevor LithgowInfection & Immunity Program, Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Australia.
Adam F CunninghamInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Manuel BanzhafInstitute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.
Michael Overduin *School of Biosciences, University of Birmingham, Edgbaston, United Kingdom.
Ian R Henderson *Institute of Microbiology and Infection, University of Birmingham, Edgbaston, United Kingdom.ORCID 0000-0002-9954-4977
University of Birmingham · GBNational University of Singapore · SGAustralian Regenerative Medicine Institute · AUThe University of Queensland · AUUniversity of Warwick · GBUniversity of Alberta · CA

Funding

Biotechnology and Biological Sciences Research Council BB/L00335X/1Biotechnology and Biological Sciences Research Council BB/M00810X/1Biotechnology and Biological Sciences Research Council BB/P009840/1Campus Alberta Neuroscience RCP-12-002CNatural Sciences and Engineering Research Council of Canada RCP-12-002CNatural Sciences and Engineering Research Council of Canada RGPIN-2018-04994
6 · The paper itself

Abstract

The Gram-negative outer-membrane envelops the bacterium and functions as a permeability barrier against antibiotics, detergents, and environmental stresses. Some virulence factors serve to maintain the integrity of the outer membrane, including DolP (formerly YraP) a protein of unresolved structure and function. Here, we reveal DolP is a lipoprotein functionally conserved amongst Gram-negative bacteria and that loss of DolP increases membrane fluidity. We present the NMR solution structure for

Indexed as

Anti-Bacterial AgentsBacterial Outer Membrane ProteinsCell MembraneCell WallEscherichia coliEscherichia coli ProteinsGram-Negative BacteriaLipoproteinsProtein TransportVirulence FactorsAnti-Bacterial AgentsBacterial Outer Membrane ProteinsEscherichia coli ProteinsLipoproteinsVirulence FactorsbiochemistryBON domaincell divisionchemical biologyE. coliEscherichia coliinfectious diseasemicrobiologyphospholipidsYraP

Identifiers

PMID33315009
PMCPMC7806268
OpenAlexW3112085725

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.